Dermatology
Direct proximity to dermatology specialists who prescribe relevant medicines in routine clinical practice.
- Prescriber access and engagement
- Real-world treatment pathways
- Adoption research for specialist therapies
Therapeutic areas
Specialist coverage where access to the right clinicians and a clear view of treatment pathways matter most.
Neurology
Experience across neurological conditions, specialist prescribing and rare neurological diseases.
- Specialist clinician research
- Treatment-pathway assessment
- Complex referral dynamics
Oncology
Work across oncology markets with complex pathways, specialist centres and high-value therapies.
- Line-of-therapy dynamics
- Specialist interviews
- Target product profile response
Rare disease
Research in small populations, specialist centres and highly concentrated treatment pathways.
- Difficult-to-recruit clinicians
- Patient and caregiver insight
- Concentrated centre-of-excellence pathways
Rheumatology
Research with rheumatology specialists across inflammatory and autoimmune conditions, treatment sequencing and biologic / advanced therapy adoption.
- Specialist rheumatologist engagement
- Treatment sequencing and switching
- Biologic and advanced therapy adoption
Metabolic disease and obesity
Relevant for GLP-1 therapies, obesity treatment, diabetes, peptide therapeutics and related cardiometabolic questions.
- Obesity and diabetes markets
- Peptide therapeutics
- Muscle preservation and sarcopenia
- Cardiometabolic positioning
We describe capability carefully. Experience varies by programme; we do not overstate coverage beyond what the team can support.
Tell us about the decision you need to make.
Share the commercial or development question you are facing. We will come back with a clear view on approach, markets and timing.